The Mesenchymal Stem Cell biomarker study

The Mesenchymal Stem Cell biomarker study - MSC biomarker study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON41879

Enrollment

Registered

2015-04-28

Start date

2015-09-07

Completion date

Unknown

Last updated

2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer tumors

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) Patients with a histologically proven malignancy of one of the following types: colorectal cancer, gastric cancer, prostate cancer or sarcoma. 2) Undergoing venous blood sampling as part of standard of care diagnostics or intravenous access in place to allow for blood withdrawal. 3) Patients must have given written informed consent before any study specific procedures.

Exclusion criteria

Exclusion criteria: 1) Patients, currently receiving anti-cancer treatment are not eligible to participate in this study.

Design outcomes

Primary

Measure	Time frame
MSCs count in peripheral blood	—

Secondary

Measure	Time frame
-	—

Countries

Netherlands

Outcome results